What is Genzyme Biosurgerys orthopaedic portfolio?
FB: Genzyme has been involved in autologous cell therapy products for over 20 years so our expertise in this area is unparalleled. But were continually investing in, and improving, our products still further. Weve developed proprietary methodologies for validating the Viability, Identity and Potency (VIP) of our cultured chondrocytes. These assays were presented at the most recent ICRS meeting in Warsaw and the papers received Cum Laude awards from the scientific committee. Its part of my role to ensure that clinicians understand the way that this testing can translate into real clinical benefits.
